Wu NY - Search Results

1

Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study.

Ouyang P, Cai J, Gui L, Liu S, Wu NY, Wang J. Ouyang P, et al. Among authors: wu ny. Arch Gynecol Obstet. 2020 May;301(5):1247-1255. doi: 10.1007/s00404-020-05505-6. Epub 2020 Mar 27. Arch Gynecol Obstet. 2020. PMID: 32221709 Free PMC article.

2

TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.

Liu L, Wu N, Wang Y, Zhang X, Xia B, Tang J, Cai J, Zhao Z, Liao Q, Wang J. Liu L, et al. J Exp Clin Cancer Res. 2019 Feb 28;38(1):106. doi: 10.1186/s13046-019-1061-y. J Exp Clin Cancer Res. 2019. PMID: 30819230 Free PMC article.

3

High methylation of ZNF582 in cervical adenocarcinoma affects radiosensitivity and prognosis.

Wu NY, Zhang X, Chu T, Zhu S, Deng Y, Zhou Y, Wang Y, Zhao X, Liu L, Fang C, Wang Y, Liou YL, Cai J, Wang J. Wu NY, et al. Ann Transl Med. 2019 Jul;7(14):328. doi: 10.21037/atm.2019.06.15. Ann Transl Med. 2019. PMID: 31475198 Free PMC article.

4

Natural history of ovarian high-grade serous carcinoma from time effects of ovulation inhibition and progesterone clearance of p53-defective lesions.

Wu NY, Fang C, Huang HS, Wang J, Chu TY. Wu NY, et al. Mod Pathol. 2020 Jan;33(1):29-37. doi: 10.1038/s41379-019-0370-1. Epub 2019 Sep 26. Mod Pathol. 2020. PMID: 31558785 Free article. Review.

5

SOX2OT, a novel tumor-related long non-coding RNA.

Wang Y, Wu N, Luo X, Zhang X, Liao Q, Wang J. Wang Y, et al. Biomed Pharmacother. 2020 Mar;123:109725. doi: 10.1016/j.biopha.2019.109725. Epub 2019 Dec 25. Biomed Pharmacother. 2020. PMID: 31865145 Free article. Review.

6

PARP inhibitor resistance: the underlying mechanisms and clinical implications.

Li H, Liu ZY, Wu N, Chen YC, Cheng Q, Wang J. Li H, et al. Mol Cancer. 2020 Jun 20;19(1):107. doi: 10.1186/s12943-020-01227-0. Mol Cancer. 2020. PMID: 32563252 Free PMC article. Review.

7

SOX1 and PAX1 Are Hypermethylated in Cervical Adenocarcinoma and Associated with Better Prognosis.

Zhao Z, Zhang X, Zhao X, Cai J, Wu NY, Wang J. Zhao Z, et al. Among authors: wu ny. Biomed Res Int. 2020 Dec 7;2020:3981529. doi: 10.1155/2020/3981529. eCollection 2020. Biomed Res Int. 2020. PMID: 33376722 Free PMC article.

8

PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer.

Hong T, Lei G, Chen X, Li H, Zhang X, Wu N, Zhao Y, Zhang Y, Wang J. Hong T, et al. Redox Biol. 2021 Jun;42:101928. doi: 10.1016/j.redox.2021.101928. Epub 2021 Mar 5. Redox Biol. 2021. PMID: 33722571 Free PMC article.

9

Development of a novel transcription factors-related prognostic signature for serous ovarian cancer.

Li H, Wu N, Liu ZY, Chen YC, Cheng Q, Wang J. Li H, et al. Sci Rep. 2021 Mar 30;11(1):7207. doi: 10.1038/s41598-021-86294-z. Sci Rep. 2021. PMID: 33785763 Free PMC article.

10

Radiomic Score as a Potential Imaging Biomarker for Predicting Survival in Patients With Cervical Cancer.

Li H, Zhu M, Jian L, Bi F, Zhang X, Fang C, Wang Y, Wang J, Wu N, Yu X. Li H, et al. Front Oncol. 2021 Aug 16;11:706043. doi: 10.3389/fonc.2021.706043. eCollection 2021. Front Oncol. 2021. PMID: 34485139 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters